Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 3Phase NA 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 5Drug-Related Side Effects and Adverse Reactions 2Colorectal Neoplasms 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Quality of Life 1Peritoneal Metastases From Gastric Cancer 1Ovarian Cancer Recurrent 1Osteosarcoma 1Meningioma 1Immune Checkpoint Inhibition 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Adenocarcinoma 1

Interventions

apatinib 2trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1Fecal Microbiota Transplantation 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Advanced Gastric Cancer × apatinib × Clear all
NCT07371871 2026-01-28

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Anhui Provincial Cancer Hospital

Phase NA Not yet recruiting
30 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03255811 2017-08-21

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

Guangdong Provincial People's Hospital

Phase NA Unknown
40 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡